Dossier
dulaglutide
Coverage of dulaglutide in the Nexus archive.
GLP-1 medicationstopic2liraglutidetopic2semaglutidetopic2ENDO 2026organization1hypothalamic-pituitary-gonadal (HPG) axistopic1functional hypogonadismtopic1Anthony Puopoloperson1RexMDorganization1Sajana Maharjanperson1Ozempictopic1Wegovytopic1Endocrine Societyorganization1National Institutes of Healthorganization1tirzepatidetopic1Dr. Peter Balazsperson1
- Popular weight-loss drugs linked to unexpected male fertility benefit
GLP-1 weight-loss drugs may improve male fertility by enhancing testosterone levels and semen quality in obese men with low testosterone. A review of five trials found no suppression of male reproductive hormones and potential benefits for metabolic health, though more research is needed.
- Ozempic users may be making a major weight-loss mistake, new study suggests
A new study suggests that adults taking GLP-1 medications like Ozempic or Wegovy for weight loss are significantly reducing their physical activity, with decreases in daily steps and moderate-to-vigorous exercise. Researchers emphasize that exercise remains essential for preserving strength and long-term health when using these drugs, despite the observed decline in activity.